Concepedia

Publication | Open Access

Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose

DOIFull Paper Access

40

Citations

13

References

2019

Year

Stefanie Jilg, Richard Hauch, Johanna Kauschinger, Lars Buschhorn, Timo O. Odinius, Veronika Dill, Catharina Müller‐Thomas, Tobias Herold, Peter Michael Prodinger, Burkhard Schmidt,
Experimental Hematology and Oncology

References

YearCitations

Page 1